Free Trial

Mettler-Toledo International (MTD) Stock Forecast & Price Target

Mettler-Toledo International logo
$1,236.12 +14.29 (+1.17%)
Closing price 08/7/2025 03:59 PM Eastern
Extended Trading
$1,237.08 +0.95 (+0.08%)
As of 08/7/2025 06:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Mettler-Toledo International - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
5
Buy
5

Based on 10 Wall Street analysts who have issued ratings for Mettler-Toledo International in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 10 analysts, 5 have given a hold rating, and 5 have given a buy rating for MTD.

Consensus Price Target

$1,288.89
4.27% Upside
According to the 10 analysts' twelve-month price targets for Mettler-Toledo International, the average price target is $1,288.89. The highest price target for MTD is $1,450.00, while the lowest price target for MTD is $1,110.00. The average price target represents a forecasted upside of 4.27% from the current price of $1,236.13.
Get the Latest News and Ratings for MTD and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Mettler-Toledo International and its competitors.

Sign Up

MTD Analyst Ratings Over Time

TypeCurrent Forecast
8/8/24 to 8/8/25
1 Month Ago
7/9/24 to 7/9/25
3 Months Ago
5/10/24 to 5/10/25
1 Year Ago
8/9/23 to 8/8/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
5 Buy rating(s)
5 Buy rating(s)
3 Buy rating(s)
2 Buy rating(s)
Hold
5 Hold rating(s)
7 Hold rating(s)
6 Hold rating(s)
4 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
2 Sell rating(s)
Consensus Price Target$1,288.89$1,282.64$1,296.13$1,343.75
Forecasted Upside4.27% Upside5.15% Upside20.02% Upside-3.70% Downside
Consensus Rating
Moderate Buy
Hold
Hold
Hold

MTD Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MTD Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Mettler-Toledo International Stock vs. The Competition

TypeMettler-Toledo InternationalMedical CompaniesS&P 500
Consensus Rating Score
2.50
2.81
2.53
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside4.27% Upside12,698.53% Upside14.09% Upside
News Sentiment Rating
Positive News

See Recent MTD News
Neutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
8/4/2025Evercore ISI
3 of 5 stars
Vijay Kumar
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOutperform ➝ Outperform$1,280.00 ➝ $1,275.00+3.99%
8/4/2025Robert W. Baird
2 of 5 stars
Catherine Schulte
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetNeutral ➝ Neutral$1,210.00 ➝ $1,230.00+2.60%
6/26/2025Bank of America
4 of 5 stars
Derik De Bruin
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetNeutral ➝ Neutral$1,200.00 ➝ $1,260.00+5.89%
6/24/2025Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Luke Sergott
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$1,325.00+13.78%
5/20/2025UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Dan Leonard
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$1,530.00 ➝ $1,350.00+16.46%
5/5/2025Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Brandon Couillard
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetEqual Weight ➝ Equal Weight$1,125.00 ➝ $1,200.00+8.70%
5/5/2025Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Tycho Peterson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderperform ➝ Hold$1,200.00 ➝ $1,110.00+0.55%
4/7/2025Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
P. Donnelly
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$1,400.00 ➝ $1,400.00+36.99%
12/13/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Schenkel
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoveragePeer Perform
11/11/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$1,550.00 ➝ $1,450.00+13.50%
8/5/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$1,300.00 ➝ $1,400.00+0.56%
7/9/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$1,150.00 ➝ $1,300.00-1.41%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 03:55 AM ET.


Should I Buy Mettler-Toledo International Stock? MTD Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, August 4, 2025. Please send any questions or comments about these Mettler-Toledo International pros and cons to contact@marketbeat.com.

Mettler-Toledo International
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Mettler-Toledo International Inc.:

  • The company reported earnings per share of $10.09 for the latest quarter, surpassing analysts' expectations, indicating strong financial performance.
  • Recent revenue growth of 3.9% year-over-year suggests that Mettler-Toledo International Inc. is expanding its market presence and demand for its precision instruments.
  • The current stock price is around $1,159.93, reflecting a robust valuation in the precision instruments sector.
  • Analysts have a consensus rating of "Hold" with several upgrades, indicating confidence in the company's stability and potential for future growth.
  • With a net margin of 21.46%, the company demonstrates effective cost management and profitability, which can be attractive to investors seeking reliable returns.

Mettler-Toledo International
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Mettler-Toledo International Inc. for these reasons:

  • The director's recent sale of 1,062 shares, representing an 89.85% decrease in their ownership, may raise concerns about insider confidence in the company's future performance.
  • Despite positive earnings, the company has a negative return on equity of 476.07%, which could indicate inefficiencies in generating profit from shareholders' equity.
  • Corporate insiders own only 0.77% of the company's stock, suggesting limited alignment between management and shareholder interests.
  • Some analysts have downgraded their ratings, which may reflect caution regarding the stock's future performance amidst market fluctuations.
  • Potential investors should consider the competitive landscape in the precision instruments market, which may impact Mettler-Toledo International Inc.'s growth prospects.

MTD Forecast - Frequently Asked Questions

According to the research reports of 10 Wall Street equities research analysts, the average twelve-month stock price forecast for Mettler-Toledo International is $1,288.89, with a high forecast of $1,450.00 and a low forecast of $1,110.00.

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Mettler-Toledo International in the last year. There are currently 5 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" MTD shares.

According to analysts, Mettler-Toledo International's stock has a predicted upside of 4.27% based on their 12-month stock forecasts.

Over the previous 90 days, Mettler-Toledo International's stock had 1 upgrade by analysts.

Mettler-Toledo International has been rated by research analysts at Bank of America, Barclays, Evercore ISI, Robert W. Baird, and UBS Group in the past 90 days.

Analysts like Mettler-Toledo International less than other "medical" companies. The consensus rating score for Mettler-Toledo International is 2.50 while the average consensus rating score for "medical" companies is 2.81. Learn more on how MTD compares to other companies.


This page (NYSE:MTD) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners